Your browser doesn't support javascript.
loading
Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02).
Hasegawa, Tsukasa; Ariyasu, Ryo; Tanaka, Hisashi; Saito, Ryota; Kawashima, Yosuke; Horiike, Atsushi; Sakatani, Toshio; Tozuka, Takehiro; Shiihara, Jun; Saiki, Masafumi; Tambo, Yuichi; Sonoda, Tomoaki; Miyazaki, Akito; Uematsu, Shinya; Tsuchiya-Kawano, Yuko; Yanagitani, Noriko; Nishino, Makoto.
Afiliación
  • Hasegawa T; Division of Respiratory Disease, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan.
  • Ariyasu R; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. ryo.ariyasu@jfcr.or.jp.
  • Tanaka H; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Saito R; Department of Respiratory Medicine, Tohoku University Hospital, Sendai, Japan.
  • Kawashima Y; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan.
  • Horiike A; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Sakatani T; Division of Respiratory, NTT Medical Center, Tokyo, Japan.
  • Tozuka T; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
  • Shiihara J; Department of Pulmonary Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Saiki M; Department of Respiratory Medicine, Graduate School of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Tambo Y; Department of Respiratory Medicine, Kanazawa University, Kanazawa, Japan.
  • Sonoda T; Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Miyazaki A; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.
  • Uematsu S; Department of Respiratory Medicine, Osaka Red Cross Hospital, Osaka, Japan.
  • Tsuchiya-Kawano Y; Department of Respiratory Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
  • Yanagitani N; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nishino M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Cancer Chemother Pharmacol ; 92(1): 29-37, 2023 07.
Article en En | MEDLINE | ID: mdl-37243795
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Japón